Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pfizer Inc. (PFE:NYSE), powered by AI.
Pfizer Inc. is currently trading at $26.04. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pfizer Inc. on Alpha Lenz.
Pfizer Inc.'s P/E ratio is 19.0.
“Pfizer Inc. trades at a P/E of 19.0 (fair value) with solid ROE of 8.9%. Operating margin of 25.2% indicates strong profitability.”
Ask for details →Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.
“Pfizer Inc. trades at a P/E of 19.0 (fair value) with solid ROE of 8.9%. Operating margin of 25.2% indicates strong profitability.”
Ask for details →Pfizer Inc. (ticker: PFE) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 81,000 employees. Market cap is $148.0B.
The current price is $26.04 with a P/E ratio of 19.04x and P/B of 1.71x.
ROE is 8.90% and operating margin is 25.24%. Annual revenue is $62.6B.